Non-tuberculous mycobacteria (NTM) are emerging worldwide as significant causes of
chronic pulmonary infection, posing a number of challenges for both clinicians and …

Introduction: The number of patients with pulmonary disease caused by non-tuberculous
mycobacteria (NTM) is increasing globally. Poor resistance against infections, for example …

Objectives To describe the global trends of pulmonary nontuberculous mycobacteria (NTM)
infection and disease. Methods A systematic review of studies including culture-based NTM …

Nontuberculous mycobacterial pulmonary disease (NTM-PD) continues to impose a
significant clinical burden of disease on susceptible patients. The incidence of NTM-PD is …

Non-tuberculous mycobacteria (NTM) are ubiquitous dwellers of environmental niches and
are an established cause of natural and nosocomial infections. The incidence of NTM …

Nontuberculous mycobacteria (NTM) are emerging pathogens that affect both
immunocompromised and immunocompetent patients. The development of molecular …

Nontuberculous mycobacterial pulmonary disease (NTM-PD) is a challenging infection
which is becoming increasingly prevalent, particularly in the elderly, for reasons which are …

Over the past several years, the prevalence of human disease caused by nontuberculous
mycobacteria (NTM) has increased. Whether the increase in cases is real or whether more …

For decades, the incidence of pulmonary nontuberculous mycobacteria (NTM) has been
reported to be increasing, yet formal epidemiological evaluation of this notion has been …

Nontuberculous mycobacteria (NTM) are emerging pathogens that affect both
immunocompromised and immunocompetent patients. The incidence and prevalence of …